Patent · US Active

Humanized anti-EGFL7 antibodies and methods using same

US8574576B2 · kind B2 · utility

1Cited by
57References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 2, 2012
Grant dateNov 5, 2013
Priority date—
Expiry dateNov 2, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention concerns antibodies to EGFL7 and the uses of same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.